William Hildebrand to Acetylglucosamine
This is a "connection" page, showing publications William Hildebrand has written about Acetylglucosamine.
Connection Strength
0.099
-
Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors. J Immunother Cancer. 2022 Oct; 10(10).
Score: 0.050
-
Single-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing. Clin Transl Med. 2022 07; 12(7):e937.
Score: 0.049